Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
AstraZeneca
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
BeOne Medicines
AstraZeneca
Tongji Hospital
Nanfang Hospital, Southern Medical University
Tongji Hospital
Tongji Hospital
Tongji Hospital
M.D. Anderson Cancer Center
Teclison Ltd.
VA Office of Research and Development
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Seoul National University Hospital
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
AstraZeneca
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bayer
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
T-ACE Medical Co., Ltd
Canadian Cancer Trials Group
Zymeworks BC Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
National Hepatology & Tropical Medicine Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TaiRx, Inc.
Seoul National University Hospital
7 Hills Pharma, LLC
Seoul National University Hospital
Nammi Therapeutics Inc
Coherus Oncology, Inc.
RayzeBio, Inc.
National Cancer Institute (NCI)
Peking University
National Cancer Institute (NCI)
Seoul National University Hospital
TaiRx, Inc.
Tongji Hospital
Beijing Biotech
National Health Research Institutes, Taiwan
OncoC4, Inc.
Parabilis Medicines, Inc.
Tuen Mun Hospital
Compass Therapeutics